Pure Global
NCT05381571

Integrating Reminiscence Technology Into Exercise Programs in Subacute Care

Bruyere Research Institute·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Rehabilitation
Drug/Device/Intervention
Motivating reminiscence physical therapy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Bruyere Research Institute
Location
Ottawa, Canada
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2022
End date
Apr 01, 2023
Enrollment
60 participants
Primary outcome

Participant Recruitment,Number of participants retained,Rate of adverse events,Staff Acceptance

Summary

This study evaluates the feasibility of a randomized controlled trial to evaluate the impact
 of motivating reminiscence-based therapy on exercise adherence, mood and physical health
 within a subacute rehabilitation population. The jDome BikeAround technology displays
 user-specified Google Earth images onto a domed screen as the user pedals on a stationary
 bike, which fosters the experience of bicycling through that given environment. Participants
 will use the technology for 12 weeks during their regularly scheduled therapy sessions.

ICD-10 classifications
Care involving use of rehabilitation proceduresDrug rehabilitationCare involving use of other rehabilitation proceduresCare involving use of rehabilitation procedure, unspecifiedPersonal history of rehabilitation measures
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05381571
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05381571 through Pure Global AI's free database. This phase not specified trial is sponsored by Bruyere Research Institute and is currently Recruiting. The study focuses on Rehabilitation. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.